Home > News > SurgRx Secures $4.5 Million in Third Round Funding
March 11th, 2004
SurgRx Secures $4.5 Million in Third Round Funding
SurgRx, a developer of proprietary nanotechnology designed to control the delivery of electro surgical energy in surgical sealing instruments, announced today that it has received $4.5 million in C round funding from Prospect Ventures, a venture capital firm focused on investments in biomedical and healthcare innovation. This announcement follows on the heels of the Company's announcement last month that it received $5 million in second round financing from California Technology Ventures.
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014